Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.
2.

SNP-SNP interactions in breast cancer susceptibility.

Onay VU, Briollais L, Knight JA, Shi E, Wang Y, Wells S, Li H, Rajendram I, Andrulis IL, Ozcelik H.

BMC Cancer. 2006 May 3;6:114.

3.

Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York.

Gaudet MM, Bensen JT, Schroeder J, Olshan AF, Terry MB, Eng SM, Teitelbaum SL, Britton JA, Lehman TA, Neugut AI, Ambrosone CB, Santella RM, Gammon MD.

Breast Cancer Res Treat. 2006 Sep;99(2):235-40. Epub 2006 Apr 5.

PMID:
16596327
4.

Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.

Tommiska J, Eerola H, Heinonen M, Salonen L, Kaare M, Tallila J, Ristimäki A, von Smitten K, Aittomäki K, Heikkilä P, Blomqvist C, Nevanlinna H.

Clin Cancer Res. 2005 Jul 15;11(14):5098-103.

5.

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients.

Kilpivaara O, Bartkova J, Eerola H, Syrjäkoski K, Vahteristo P, Lukas J, Blomqvist C, Holli K, Heikkilä P, Sauter G, Kallioniemi OP, Bartek J, Nevanlinna H.

Int J Cancer. 2005 Feb 10;113(4):575-80.

6.

Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients.

Sazci A, Ergul E, Utkan NZ, Canturk NZ, Kaya G.

Toxicology. 2004 Nov 15;204(2-3):197-202.

PMID:
15388245
7.

The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer.

John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O'Malley FP, Santella RM, Southey MC, Venne VL, Venter DJ, West DW, Whittemore AS, Seminara D; Breast Cancer Family Registry.

Breast Cancer Res. 2004;6(4):R375-89. Epub 2004 May 19.

8.

A family-based genetic association study of variants in estrogen-metabolism genes COMT and CYP1B1 and breast cancer risk.

Ahsan H, Chen Y, Whittemore AS, Kibriya MG, Gurvich I, Senie RT, Santella RM.

Breast Cancer Res Treat. 2004 May;85(2):121-31.

PMID:
15111770
9.

Single nucleotide polymorphisms in breast cancer.

Försti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, Pamula J, Pekala W, Zientek H, Hemminki K, Kumar R.

Oncol Rep. 2004 Apr;11(4):917-22.

PMID:
15010895
10.

Statistics review 8: Qualitative data - tests of association.

Bewick V, Cheek L, Ball J.

Crit Care. 2004 Feb;8(1):46-53. Epub 2003 Dec 30. Review.

11.

The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer.

Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Weitzer W, Leithner A, Samonigg H.

Breast Cancer Res Treat. 2003 Dec;82(3):165-8.

PMID:
14703063
12.

Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.

Grieu F, Malaney S, Ward R, Joseph D, Iacopetta B.

Anticancer Res. 2003 Sep-Oct;23(5b):4257-9.

PMID:
14666635
13.

An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.

Lu F, Gladden AB, Diehl JA.

Cancer Res. 2003 Nov 1;63(21):7056-61.

14.

Statistical aspects of the analysis of data from retrospective studies of disease.

MANTEL N, HAENSZEL W.

J Natl Cancer Inst. 1959 Apr;22(4):719-48. No abstract available.

PMID:
13655060
15.

Measuring inconsistency in meta-analyses.

Higgins JP, Thompson SG, Deeks JJ, Altman DG.

BMJ. 2003 Sep 6;327(7414):557-60. Review. No abstract available.

16.

Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1.

Dawling S, Roodi N, Parl FF.

Cancer Res. 2003 Jun 15;63(12):3127-32.

17.

Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.

Doisneau-Sixou SF, Sergio CM, Carroll JS, Hui R, Musgrove EA, Sutherland RL.

Endocr Relat Cancer. 2003 Jun;10(2):179-86. Review.

18.

Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk.

Wedrén S, Rudqvist TR, Granath F, Weiderpass E, Ingelman-Sundberg M, Persson I, Magnusson C.

Carcinogenesis. 2003 Apr;24(4):681-7.

PMID:
12727796
19.

Cycling to cancer with cyclin D1.

Diehl JA.

Cancer Biol Ther. 2002 May-Jun;1(3):226-31. Review.

PMID:
12432268
20.

Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.

Kocabaş NA, Sardaş S, Cholerton S, Daly AK, Karakaya AE.

Arch Toxicol. 2002 Nov;76(11):643-9. Epub 2002 Aug 21.

PMID:
12415427

Supplemental Content

Support Center